logo

For the Inventor, By the Inventor

Leymen, France

Benjamin Martin

This inventor holds 8 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Novartis Ag, Mereo Biopharma 1 Limited, Other. Active years: 2019-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Benjamin Martin. Retrieved from https://idiyas.com/inventor/benjamin-martin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8 

% Patents Active = 100.0


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Leymen, FR (2019 - 2023)
  • Basel, CH (2019 - 2023)

Company Filing History:

goldMedal6 out of 3,978 
 
Novartis Ag
 patents
silverMedal1 out of 10 
 
Mereo Biopharma 1 Limited
 patents
bronzeMedal1 out of 834,601 
Other
 patents

Years Active: 2019-2023

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents
1. 11649213 - Synthetic method for the preparation of a 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol compound (2023-05-16),
2. 11578053 - Chemical process for preparing phenylpiperidinyl indole derivatives (2023-02-14),
3. 11434192 - Process and intermediates (2022-09-06),
4. 11208398 - Chemical process for preparing phenylpiperidinyl indole derivatives (2021-12-28),
5. 10851059 - Processes and intermediates for NEP inhibitor synthesis (2020-12-01),
6. 10633341 - Picolinic acid derivatives and their use as intermediates (2020-04-28),
7. 10385004 - Process and intermediates for the preparation of NEP inhibitors (2019-08-20),
8. 10377697 - Process and intermediates (2019-08-13),

Introduction

Benjamin Martin, located in Leymen, France, is a prolific inventor with a notable portfolio of 8 patents. His contributions to the field of chemistry and pharmaceuticals highlight his innovative spirit and commitment to advancing scientific knowledge.

Latest Patents

Among his recent inventions, Benjamin has developed a synthetic method for the preparation of a 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol compound. This process involves reacting a specific compound with another to yield a key compound or its salt or solvate, showcasing his expertise in synthetic chemistry. Additionally, he has created a chemical process for preparing phenylpiperidinyl indole derivatives, which outlines a method for synthesizing a compound that has significant pharmaceutical applications.

Career Highlights

Benjamin Martin has made substantial contributions to the pharmaceutical industry through his work at notable organizations such as Novartis AG. His innovative approaches in the lab have led to advancements in drug development and therapeutic solutions.

Collaborations

Throughout his career, Benjamin has worked alongside talented colleagues, including Francesco Venturoni and Florian Karl Kleinbeck-Riniker. These collaborations emphasize the collaborative nature of innovation in the scientific community, as ideas and discoveries often stem from teamwork and shared expertise.

Conclusion

Benjamin Martin's journey as an inventor exemplifies the profound impact that creativity and research can have on technology and medicine. His recent patents reflect not only his individual brilliance but also the collaborative effort required to push the boundaries of what's possible in the field of chemistry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…